Related Experiment Videos
Amiodarone-an "old" drug with new recommendations
1Pediatric Emergency Medicine, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010, USA. mmckee@cnmc.org
Current Opinion in Pediatrics
|March 18, 2003
Summary
Amiodarone is an antiarrhythmic drug recommended for pediatric resuscitation. Current pediatric data show limited efficacy, indicating a need for more research before widespread clinical acceptance.
Area of Science:
- Cardiology
- Pediatric Emergency Medicine
- Pharmacology
Background:
- Amiodarone is an antiarrhythmic medication gaining attention following revised pediatric resuscitation guidelines.
- While adult use is well-supported, pediatric data on amiodarone efficacy is limited.
- There is a critical need for more research on amiodarone in pediatric acute resuscitation.
Purpose of the Study:
- To review amiodarone properties relevant to pediatric resuscitation.
- To analyze existing pediatric studies on amiodarone's efficacy and safety.
- To provide healthcare providers with information for informed antiarrhythmic choices in pediatric emergencies.
Main Methods:
- Literature review of amiodarone properties.
- Analysis of published pediatric studies concerning amiodarone use in resuscitation.
- Discussion of the challenges in conducting prospective pediatric trials.
Main Results:
- Limited pediatric studies indicate restricted efficacy of amiodarone.
- Existing research highlights a significant need for further pediatric data.
- Controlled prospective studies in pediatric resuscitation are ethically challenging.
Conclusions:
- Healthcare providers must carefully evaluate the available pediatric evidence for amiodarone.
- The current pediatric data may not support the widespread adoption of amiodarone in treatment regimens.
- Further investigation is crucial to determine amiodarone's role in pediatric acute resuscitation.